Literature DB >> 15824121

Vitamin D receptor-dependent regulation of colon multidrug resistance-associated protein 3 gene expression by bile acids.

Tanya C McCarthy1, Xiufeng Li, Christopher J Sinal.   

Abstract

The multidrug resistance-associated protein 3 (MRP3) is a multispecific anion transporter that is capable of transporting a number of conjugated and unconjugated bile acids. Expression of the MRP3 gene is increased during pathological states associated with elevated bile acid concentrations indicating a role for this transporter in adaptive and homeostatic bile acid metabolism. Analysis of Mrp3 mRNA levels in various mouse tissues with known relevance and/or exposure to bile acids revealed the highest levels of basal expression in the colon followed in order by the liver, duodenum, jejunum, ileum, and kidney. Functional analysis of a murine Mrp3 promoter reporter construct revealed vitamin D receptor (VDR)-dependent activation by 1,25-dihydroxyvitamin D(3) (VD3), 9-cis-retinoic acid (RA), and the cholestatic secondary bile acid, lithocholic acid (LCA). Using a series of deletion constructs combined with sequence analysis, a candidate VDR response element (VDRE) was identified between -1028 and -1014 bp of the Mrp3 promoter. Activation of the Mrp3 promoter in response to VD3, RA, or LCA, as well as binding of VDR/RXR heterodimers, was attenuated substantially by mutation of this VDRE. Treatment of mice with VD3 or LCA demonstrated in vivo modulation of the Mrp3 gene in colon but not in the liver. Reduction of endogenous VDR expression in colon adenocarcinoma MCA-38 cells by siRNA transfection was associated with reduced constitutive and inducible expression of the Mrp3 gene. These data support a regulatory role for the VDR in the protection of colon cells from bile acid toxicity through regulation of the Mrp3 expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15824121     DOI: 10.1074/jbc.M411520200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

Review 1.  Regulation of hepatic ABCC transporters by xenobiotics and in disease states.

Authors:  Xinsheng Gu; Jose E Manautou
Journal:  Drug Metab Rev       Date:  2010-08       Impact factor: 4.518

Review 2.  Nuclear receptors in bile acid metabolism.

Authors:  Tiangang Li; John Y L Chiang
Journal:  Drug Metab Rev       Date:  2013-02       Impact factor: 4.518

3.  Vitamin D is not linked to folate status and mRNA expression of intestinal proton-coupled folate transporter.

Authors:  C Brandsch; J Zibolka; M Frommhagen; U Lehmann; J Dierkes; H Kühne; F Hirche; G I Stangl
Journal:  Eur J Nutr       Date:  2013-11-05       Impact factor: 5.614

4.  Mechanism of vitamin D receptor inhibition of cholesterol 7alpha-hydroxylase gene transcription in human hepatocytes.

Authors:  Shuxin Han; John Y L Chiang
Journal:  Drug Metab Dispos       Date:  2008-12-23       Impact factor: 3.922

Review 5.  Nuclear receptors as therapeutic targets in cholestatic liver diseases.

Authors:  Gernot Zollner; Michael Trauner
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

Review 6.  The intestinal absorption of folates.

Authors:  Michele Visentin; Ndeye Diop-Bove; Rongbao Zhao; I David Goldman
Journal:  Annu Rev Physiol       Date:  2014       Impact factor: 19.318

7.  Lithocholic acid down-regulation of NF-kappaB activity through vitamin D receptor in colonic cancer cells.

Authors:  Jun Sun; Reba Mustafi; Sonia Cerda; Anusara Chumsangsri; Yinglin Rick Xia; Yan Chun Li; Marc Bissonnette
Journal:  J Steroid Biochem Mol Biol       Date:  2008-04-25       Impact factor: 4.292

Review 8.  Bile Acid Metabolism and Signaling in Cholestasis, Inflammation, and Cancer.

Authors:  Tiangang Li; Udayan Apte
Journal:  Adv Pharmacol       Date:  2015-05-27

9.  Intestinal CYP3A4 protects against lithocholic acid-induced hepatotoxicity in intestine-specific VDR-deficient mice.

Authors:  Jie Cheng; Zhong-Ze Fang; Jung-Hwan Kim; Kristopher W Krausz; Naoki Tanaka; John Y L Chiang; Frank J Gonzalez
Journal:  J Lipid Res       Date:  2013-12-16       Impact factor: 5.922

10.  Vitamin D analogs combined with 5-fluorouracil in human HT-29 colon cancer treatment.

Authors:  Magdalena Milczarek; Beata Filip-Psurska; Wiesław Swiętnicki; Andrzej Kutner; Joanna Wietrzyk
Journal:  Oncol Rep       Date:  2014-06-11       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.